Mycobacterium tuberculosis complex, AFB Agar Proportion Drugs, Ethionamide Susceptibility

Laboratory Fee Schedule
Procedure #:   MAD0067A  
CPT: 87190

Synonym(s): M. tuberculosis complex drug susceptibility test (DST), ETO DST, ETH DST
Requisition FormG-MYCO
Test DescriptionSusceptibility test to Ethionamide by agar proportion method.
Pre-Approval NeededN/A
Supplemental Information RequiredN/A
Supplemental Form(s)N/A
Performed on Specimens from (sources)Pure isolate from human sources.
Sample/Specimen Type for TestingM. tuberculosis complex pure isolate in liquid or on solid culture medium.
Minimum Volume/Size Required
  • Liquid culture-2.0 mL
  • Solid culture-Visible growth, more than a single colony
Storage/Preservation Prior to ShippingAmbient 
Transport MediumN/A
Specimen Labeling
  • At least two patient identifiers required on specimen (e.g., patient full name, date of birth, medical record number). 
  • Three patient identifiers are preferred. 
  • Patient identifiers on specimen label must exactly match identifiers on submission form. (e.g., abbreviated name on label and full name on form is not acceptable.)
  • Additional DSHS Laboratory specimen labeling guidelines available online here.
     
Shipping and Specimen Handling Requirements
  • Ship according to Dangerous Goods Regulations, IATA, and/or CFR 49
  • Triple-contain in accordance with federal shipping regulations for UN2814 Category A, Infectious substance, affecting humans.
  • Anyone who handles Category A substances is required by law to be trained in handling and shipping Category A, Infectious Substances.
    • Untrained personnel should not handle or ship M. tuberculosis isolates. 
  • Submitters are responsible for packaging and shipping specimens according to regulatory requirements.
     
MethodAgar proportion susceptibility test interpreted as either susceptible or resistant to a specific drug at critical concentration recommended by CLSI.
Turn-around Time14 to 21 days.
Interferences/LimitationsTest can only be performed on pure cultures of M. tuberculosis complex.
Common Causes for Rejection
  • Non-viable isolates.
  • Cultures overgrown by contaminating organisms.
  • Isolate not M. tuberculosis complex.
Additional Information
  • Isolates submitted for this test will be identified by this laboratory.  
  • No fee will be charged for this identification unless identification is requested on the G-MYCO requisition form.
  • This laboratory will notify submitter of new drug resistance detected by this test.